CS MEDICA A/S (“CS MEDICA” or the “Company”) today announces that the Company has received CANNASEN® trademark registration certificates in hong kong and New Zealand. This marks an important step in securing the brand as the company expands into the global market.
CS MEDICA A/S (“CS MEDICA” or the “Company”) today announces that the trademark offices of New Zealand and hong kong have approved CS MEDICA registered trademark CANNASEN®.
“One of the things to secure when building a global business is brands. CS MEDICA has always been active in filing patents to ensure the future of our products, but we also see the value of securing our brands with trademark registration. This is another important step we are taking in our global sales strategy.” says the CEO Lone Henriksen.
CANNASEN® brand approval is an important step in CS MEDICAmarket strategy to increase sales of its CANNASEN® product line in the global market. The trademark registration number. for CANNASEN® in New Zealand is 1440394 and is valid until November 19, 2028. The registration number. for CANNASEN® in hong kong is 305799007 and valid until November 10, 2031.
Brands from July 2022;
For more information on CS MEDICAplease contact:Lone HenriksenCEO
Telephone: + (45) 71 20 30 47
Email: [email protected]
CS MEDICA A/S is a Danish medical cannabis company founded in 2011. CS MEDICA is committed to developing, manufacturing and marketing over-the-counter (OTC) medical devices containing cannabinoids. The Company operates through two wholly owned subsidiaries, Galaxa Pharma A/S (distributor and representative of foreign manufacturers in the Nordic countries, registered distributor of medical device products) and CanNordic A/S (developer and seller (BtB), registered medical device manufacturer). CS MEDICA distributes products across European borders and is headquartered in Copenhagen, Denmark.
The company is listed on Stock market in stockholm (symbol: “CSMED”). For more information on CS MEDICA cs-medica.com.
(c) Decision 2022. All rights reserved., sources Press Releases – English